Pfizer: The financial results for the period ended September 30, 2026

What happened

Pfizer (PFIZER) filed a disclosure with the exchanges on 3 November 2026 at 02:14 PM titled "The financial results for the period ended September 30, 2026".

Company snapshot

Pfizer is a small-cap company in the Healthcare sector, with a market value of about ₹17,279 crore.

The stock last traded at ₹3,777, against a 52-week range of ₹3,589–₹5,339 (29.3% below the high).

Before this filing the shares had moved −6.1% over the month and −26.0% over three months. Average daily turnover over the last 20 sessions was about ₹10.84 crore.

Promoters held 63.92% at the end of Q1 FY27. Foreign institutions owned 1.65% and domestic institutions 17.80%.

What history shows

BCEIE's records show 1 previous results filing from the company since May 2026.

Across 300 similar disclosures by other Healthcare companies, shares moved +1.3% on average the next day and +1.9% over five days; 57% of them rose the next day.

Market-wide, 10,321 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

• Management commentary, margins and order book or guidance in the investor presentation.
• 3 November 2026: Board meeting — Financial Results.

In the news

Recent coverage elsewhere (links open the original publisher):

• Pfizer looks to reroute supply after flooding sidelined India injectables plant — Fierce Pharma, 30 Oct 2026
• Pfizer India site closure risks exacerbating cancer drug shortages — Endpoints News, 28 Oct 2026
• Pfizer stock hits 52-week high at 30.68 USD By Investing.com — Investing.com India, 2 Nov 2026
• Pfizer shares may move 3.8% on Nov. 3 earnings release By Investing.com — Investing.com India, 27 Oct 2026
• Pfizer India’s Meenakshi Nevatia on making new therapies more accessible — Business Today, 28 Oct 2026

Source

• Exchange filing (PDF)